Abbott | ABT - Current Liabilities

Stock Price
108.03
Daily Change
-0.11 -0.10%
Monthly
-3.77%
Yearly
-14.74%
Q1 Forecast
104.77

Abbott reported $16.5B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agilent USD 2.23B 113M Dec/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.94B 1.6B Sep/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Solventum Corp USD 3.14B 198M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Terumo JPY 539.7B 243.4B Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025